We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Powerful Tool Detects Fast-Spreading SARS-COV-2 Variants

By LabMedica International staff writers
Posted on 30 Jan 2025

Throughout the course of the COVID-19 pandemic, new variants of SARS-CoV-2 have emerged, each demonstrating increased transmissibility. More...

Viruses can mutate in ways that enhance their ability to infect hosts, either by increasing viral load or evading immune responses. Rapid detection of these mutations is crucial to understanding viral biology and identifying new variants that may require further investigation. Quickly identifying mutations that contribute to higher transmission rates can aid in outbreak control and help spot potential immune escape variants. However, determining how individual mutations influence viral transmission has proven to be a difficult task. To overcome this challenge, researchers have developed a tool capable of detecting SARS-CoV-2 variants with high transmission potential before they become widespread.

A team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute, Melbourne, Australia) and the University of Pittsburgh (Pittsburgh, PA, USA), analyzed millions of viral genome sequences from around the world. Their work revealed specific mutations that give SARS-CoV-2 a significant advantage in spreading. While many of these mutations were found in the virus’s spike protein, which is responsible for allowing the virus to enter human cells and is targeted by antibodies, the researchers also discovered important mutations in less-studied regions of the virus.

These mutations play a role in enhancing the virus's ability to bind to human cells, evade immune responses, or alter protein structure. Unlike previous methods, this new model, highlighted in Nature Communications, uses genomic surveillance data to accurately identify the mutations driving the spread of certain variants, even when these mutations appear in only a small fraction of cases. While the model was developed specifically for SARS-CoV-2, the researchers believe it can be adapted to track the transmission of other pathogens, such as influenza.

“Our method is like a magnifying glass for viral evolution, helping public health systems spot and monitor highly transmissible variants before they become widespread,” said Associate Professor John Barton from the University of Pittsburgh, co-lead author of the study. “Not only can we track SARS-CoV-2 more effectively, but our method can also be adapted to study the evolution of other pathogens, helping us stay ahead of future outbreaks. It’s a powerful tool for global efforts to tackle emerging diseases.”


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PlGF Test
Quidel Triage PlGF Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.